For The Better

Nvidia and Amazon are excellent ways to bet on this long-term technology megatrend.

Which of these two pharmaceutical giants should you add to your portfolio?

Weak earnings results combined with rough economic data to sink this discount retailer.

In fiscal Q3, the iconic jeanswear giant’s revenue slightly missed the Wall Street consensus estimate but earnings slightly beat it.

This may be key in maintaining its already-stellar profit margins.

Management expects weak demand trends to last through the rest of 2023.

Investors have to be critical of the company’s durability.

The Oracle of Omaha isn’t afraid to buy interest rate-sensitive stocks now.

Could this help the company offer its customers a better product package?

Eli Lilly’s drug looks better on paper, but Ozempic was on the market first.

The cloud market is booming, and these companies could profit significantly from its development.

AMD is often compared to Nvidia, but the two are quite different.

An early filing will generally leave you with a reduced monthly benefit for life, but you may be able to get out of that.

Sharply higher interest rates are hammering solar stocks in several ways.

Nvidia’s return on invested capital stands head and shoulders above even its top peers.

Riding out the hills and valleys of Shiba Inu’s price moves requires an abundance of faith and a strong stomach.

StoneCo just announced a new repurchase authorization. Here’s why that’s great news for investors.

AT&T’s dividend looks safe, but there are other factors investors should consider.

The smaller e-commerce platform has a unique value proposition.

For investors with time on their side, combining the power of dollar-cost averaging and Bitcoin could be a recipe for success.